Back to Primary literature
Primary-literature peptidehigh evidence

PEPDIA-PLP-003679

MP

Aliases: Mastoparan-L, MP

Normalized sequence

INLKALAALAKKIL

14 amino acids

Release PepDiana-V1-20260620

4

Activity records

2

Source papers

4

Positive

0

Negative / threshold

Cross-layer links

Related Integrated records

Versioned scientific descriptors

Physicochemical properties and standard representations

not calculated

Reported properties

No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.

Computed properties

physchem-20260620

Molecular weight

Not calculated

Molecular formula

Not calculated

Theoretical pI

Not calculated

Net charge at pH 7

Not calculated

GRAVY

Not calculated

Instability index

Not calculated

Aromaticity

Not calculated

Topological polar surface area

Not calculated

cLogP

Not calculated

Hydrogen-bond donors

Not calculated

Hydrogen-bond acceptors

Not calculated

Rotatable bonds

Not calculated

Method: Not recorded

Tool: Not recorded

Calculated: Not recorded

Sequence representations

representations-20260620

ProForma 2.0

Not calculated for this record

HELM 2.0

Not calculated for this record

Canonical SMILES

Not calculated for this record

Isomeric SMILES

Not calculated for this record

Paper-level observations

Experimental evidence grouped by activity

Toxicity 3 records

PMC10611374

2 observations

PMC9065177

1 observations
ToxicityHemolyticPositive observation
Record detail

The potential of the stapled MP peptides to non-specifically lyse red blood cells (RBC) was measured and their hemolytic activities (HC50) determined. The peptide MP9 displayed the lowest level of RBC hemolysis.

Measure
HD50
Value
HC50 values not explicitly given for MP; MP9 displayed the lowest level of RBC hemolysis
Target
Mus musculus
Assay
Not reported by source
Source publication
Anticancer 1 records

PMC9065177

1 observations
AnticancerCytotoxicPositive observation
Record detail

These stapled peptides were evaluated for cytotoxicity in the CRC cell line CT26 in vitro, IC50 values ranged from 1.11 μM to 9.32 μM. These stapled MP derivatives exhibited either enhanced or same anti-CRC activity, in comparison to the parent MP.

Measure
other
Value
IC50 values ranged from 1.11 μM to 9.32 μM for stapled peptides; MP IC50 not explicitly given but stated stapled derivatives exhibited enhanced or same anti-CRC activity compared to parent MP
Target
CT26
Assay
Not reported by source
Source publication

Citation and release provenance

Cite this identity as PepDiana record PEPDIA-PLP-003679, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.

Record updated: 2026-06-22T07:14:26.229247+00:00